Evidence generation strategy and planning

You need to ensure your evidence generation plans address constantly evolving treatment landscapes and payer evidence expectations, and that your plans meet the changing thresholds for demonstrating value.


We leverage our extensive experience to identify, produce, and weave together the threads of evidence needed to create the fabric of coherent and credible strategies to support market access.


In additional to high-quality strategic reviews of published evidence, we harness the power of our PRMA Healthcheck® digital application to provide a structured assessment of the risks and opportunities in multiple markets. This is based on a robust methodology that allows you to develop targeted evidence and activity roadmaps.


We also support you in planning for validating and road testing your strategies in preparation for early scientific advice or health technology assessment (HTA).


Our consulting solutions include:

  • HTA and disease area reviews
  • PRMA Healthcheck® assessments
  • clinical development plan optimization
  • HTA scientific advice planning and support
  • mock HTA/ICER appraisal meetings.


These services are provided by Avalere, PAI, PRMA Consulting, and Skysis – part of Fishawack Health.

Request a call

We have made significant progress in integrated evidence generation planning and are benefiting from insight into new methods of evidence generation thanks to our work with you.

Associate Director, Market Access, top-5 pharmaceutical company

You have a vision; we are the consulting partner that will get you there.
We would be delighted to have a confidential conversation about your market access needs.